Functionally, NSUN2 deficiency inhibits HCC cell proliferation, migration, invasion, and angiogenesis, while also increasing sensitivity to sorafenib (Song et al., 2023; Sun et al., 2020). This evidence concerns the gene NSUN2 and hepatocellular carcinoma.